Inside Therapeutics
PrivateLast Round
VC Round
Jun 3, 2025
Total Funding Raised
$1.39M
Company Overview
Inside Therapeutics is a biotechnology company that develops and markets instruments and services for the manufacturing of lipid nanoparticles for therapeutic RNA.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inside Therapeutics Comparables
Compare Inside Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreciGenome | 85% | |
| enParticle | 81% | |
| MEPSGEN | 81% | |
Inside Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 3, 2025 | ||||
| Seed | Jun 20, 2024 |
Inside Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aquiti Gestion | VC Round |
| Newfund NAEH Innopy | VC Round |
| SkalePark | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2024
$1.39M round led by newfundcap and SkalePark.
Inside Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inside Therapeutics's valuation, stock price, and market status.